Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 132 participants.

Also called NCT05708690

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 132 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05708690
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Indonesia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05708690. Randomized; triple masking; primary purpose treatment. Start 2022-10-01 (actual); primary completion 2022-12-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery
Condition
Valvular Heart Disease
Condition
Surgical Blood Loss
Intervention (Drug)
Tranexamic Acid 100 MG/ML
Intervention (Drug)
normal saline
Lead sponsor
Universitas Indonesia (class: other)

Record details

Record id
cardio:ct-nct05708690
Content hash
3c602bb825477e0d8de49a5a77b7eb34a5c2e31a66195b0dba8abd8538d100c9